SIGN UP FOR UPDATES!
Sign up for Englemed updates from TwitterSign up for Englemed updates from Facebook
ENGLEMED
Contact Englemed
Our contact email address.
We can provide a specialist, tailored health and medical news service for your site.
Click here for more information
RSS graphic XML Graphic Add to Google
About Englemed news services - services and policies.
Englemed News Blog - Ten years and counting.
Diary of a reluctant allergy sufferer - How the British National Health Service deals with allergy.
BOOKS AND GIFTS THIS WAY!
BookshopFor books on women's health, healthy eating ideas, mental health issues, diabetes, etc click here
SEARCH THIS SITE
Copyright Notice. All reports, text and layout copyright Englemed Ltd, 52 Perry Avenue, Birmingham UK B42 2NE. Co Registered in England No 7053778 Some photos copyright Englemed Ltd, others may be used with permission of copyright owners.
Disclaimer: Englemed is a news service and does not provide health advice. Advice should be taken from a medical professional or appropriate health professional about any course of treatment or therapy.
FreeDigitalPhotos
www.freedigitalphotos.net
FreeWebPhotos
www.freewebphoto.com
FROM OUR NEWS FEEDS
Dermatological map could lead to new treatments
Fri January 22nd - A newly created skin cell map offers a “huge leap” in understanding of disease and could pave the way for potential drug treatments for painful skin diseases, British researchers say. More
Half a million doctors needed for cancer surgery
Fri January 22nd - The world will need half a million more doctors in the next 20 years, just to cope with growing demand for cancer surgery, according to a major new analysis. More
RECENT COMMENTS
On 09/10/2020 William Haworth wrote:
How long is recovery time after proceedure... on Ablation cuts atrial fibrillat...
On 04/08/2020 VICKY P ADAM wrote:
I would like to thank WORLD HERBS CLINIC for reve... on Medieval remedy for bacterial ...
On 29/07/2020 Amdre wrote:
When i read many blogs online about cure to HSV, a... on Medieval remedy for bacterial ...
On 14/07/2020 margret wrote:
I was diagnosed of ALS (amyotrophic lateral sclero... on Heart abnormalities revealed i...
On 08/02/2018 David Kelly wrote:
Would you like to write a piece about this to be i... on Researchers unveil new pain re...
OUR CLIENTS
THIS WEEK'S STORIES
ENGLEMED HEALTH NEWS

Prostate cancer grading lacks accuracy

Friday April 11th, 2014

Tests to identify the severity of prostate cancer have proved wildly inaccurate, researchers warn today.

As many as 50% of men whose cancers are shown to be slow-growing by current procedures proved later to have much more aggressive disease.

And about two thirds of these were found to have cancer spreading throughout the body - although tests beforehand suggested the disease was "slow-growing."

The findings, reported in the British Journal of Cancer, highlight the problems doctors face in deciding what treatment to recommend to patients.

The researchers at Cambridge University analysed the fate of more than 800 men. They compared the stage and grade allocated to the cancer before treatment with findings after surgery.

Some 415 men were classified as having slow-growing cancer - but 209 of these were later found to have aggressive cancer. And 131 men had disease that had spread beyond the original organ.

Researcher Greg Shaw said: “This highlights the urgent need for better tests to define how aggressive a prostate cancer is from the outset, building on diagnostic tests like MRI scans, and new biopsy techniques which help to more accurately define the extent of the prostate cancer.

"This would then enable us to counsel patients with more certainty whether the prostate cancer identified is suitable for active surveillance or not.”

Professor Malcolm Mason, of Cancer Research UK, said: "We need better methods of assigning a grade and stage so that no man has to unnecessarily undergo treatment, while at the same time making sure we detect and treat the cancers that really need it."

He added: "Despite the limitations that this study shows, all evidence so far points to active surveillance being safe provided men are carefully selected."

Identification of pathologically insignificant prostate cancer is not accurate in unscreened men British Journal of Cancer 11 April 2014

Tags: Cancer | Menís Health | UK News

Printer friendly page Printer friendly page

Comment on this article:

Name:
Email:
Comment:
<a>,<b> & <p> tags allowed
Please enter the letters displayed:
(not case sensitive)
CATEGORIES